Concepedia

Lucinda J. Van Anglen

LJ

5

Publications

96

Citations

5

H-Index

2012

Active since

Affiliations

University of Houston(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Lucinda J. Van Anglen is an author at University of Houston specializing in medicine, orthopaedics, and surgery.

ORCID

Top concepts

Publications per year

2012–2023

5

Publications

5

Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study

Richard L. Hengel, Timothy E. Ritter, Ramesh V Nathan et al. · Open Forum Infectious Diseases · 2020 · 43 citations · Full text

Outpatient treatment of osteomyelitis with telavancin

Claudia P. Schroeder, Lucinda J. Van Anglen, Robin Dretler et al. · International Journal of Antimicrobial Agents · 2017 · 16 citations

, , +2

Successful Treatment of Polymicrobial Calcaneal Osteomyelitis with Telavancin, Rifampin, and Meropenem

Mary Brinkman, Kaili Fan, Renee L Shiveley et al. · Annals of Pharmacotherapy · 2012 · 14 citations

, , +17

Recurrent Clostridioides difficile infection worsens anxiety-related patient-reported quality of life

Richard L. Hengel, Claudia P. Schroeder, Jinhee Jo et al. · Journal of Patient-Reported Outcomes · 2022 · 13 citations · Full text

A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam

Lucinda J. Van Anglen, Claudia P. Schroeder, Kimberly A Couch · Open Forum Infectious Diseases · 2023 · 10 citations · Full text

Rows per page

1–5 of 5